You just read:

Health Canada Approves New Indication for the Use of Xtandi® (enzalutamide) Capsules for Patients with Metastatic Castration-Resistant Prostate Cancer

News provided by

Astellas Pharma Canada, Inc.

Apr 16, 2015, 08:00 ET